It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The non-filarial and non-communicable disease podoconiosis affects around 4 million people and is characterized by severe leg lymphedema accompanied with painful intermittent acute inflammatory episodes, called acute dermatolymphangioadenitis (ADLA) attacks. Risk factors have been associated with the disease but the mechanisms of pathophysiology remain uncertain. Lymphedema can lead to skin lesions, which can serve as entry points for bacteria that may cause ADLA attacks leading to progression of the lymphedema. However, the microbiome of the skin of affected legs from podoconiosis individuals remains unclear. Thus, we analysed the skin microbiome of podoconiosis legs using next generation sequencing. We revealed a positive correlation between increasing lymphedema severity and non-commensal anaerobic bacteria, especially Anaerococcus provencensis, as well as a negative correlation with the presence of Corynebacterium, a constituent of normal skin flora. Disease symptoms were generally linked to higher microbial diversity and richness, which deviated from the normal composition of the skin. These findings show an association of distinct bacterial taxa with lymphedema stages, highlighting the important role of bacteria for the pathogenesis of podoconiosis and might enable a selection of better treatment regimens to manage ADLA attacks and disease progression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University Hospital Bonn (UKB), Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Bonn, Germany (GRID:grid.15090.3d) (ISNI:0000 0000 8786 803X)
2 University of Buea, Department of Microbiology and Parasitology, Buea, Cameroon (GRID:grid.29273.3d) (ISNI:0000 0001 2288 3199); Research Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon (GRID:grid.29273.3d) (ISNI:0000 0001 2288 3199)
3 Bonn-Rhein-Sieg University of Applied Sciences, Institute for Functional Gene Analytics, Sankt Augustin, Germany (GRID:grid.425058.e) (ISNI:0000 0004 0473 3519)
4 University Hospital Bonn (UKB), Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Bonn, Germany (GRID:grid.15090.3d) (ISNI:0000 0000 8786 803X); German Center for Infection Research (DZIF), Neglected Tropical Disease, Partner Site, Bonn-Cologne, Bonn, Germany (GRID:grid.452463.2)
5 University Hospital Bonn (UKB), Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), Bonn, Germany (GRID:grid.15090.3d) (ISNI:0000 0000 8786 803X); German Center for Infection Research (DZIF), Neglected Tropical Disease, Partner Site, Bonn-Cologne, Bonn, Germany (GRID:grid.452463.2); German-West African Centre for Global Health and Pandemic Prevention (G-WAC), Partner Site, Bonn, Bonn, Germany (GRID:grid.452463.2)




